Skip to main content
Clinical Trials/ISRCTN13567538
ISRCTN13567538Completed未知

Individually randomised controlled multi-centre trial to determine the clinical and cost effectiveness of an adapted yoga programme for older adults with multimorbidity, including an embedded process evaluation

orthumbria University Newcastle0 sites454 target enrollmentStarted: March 18, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
454

Study Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33845869/ (added 14/04/2021) 2023 Results article in https://doi.org/10.3310/nihropenres.13465.1 (added 16/10/2023)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Current inclusion criteria as of 08/01/2021:
  • 1. Aged 65 years or older
  • 2. Community-dwelling (including sheltered housing living with support)
  • 3. Have two or more chronic health conditions from the following list:
  • 3.1 Arthritis: including osteoarthritis, rheumatoid arthritis, and history of shoulder, hip or knee arthroplasty for arthritis
  • 3.2 Asthma or chronic obstructive pulmonary disease (COPD)
  • 3.3 Atrial fibrillation
  • 3.4 A diagnosis of cancer within the last 5 years
  • 3.5 Cardiovascular disease: including coronary heart disease (includes angina or history of heart attack, bypass surgery or angioplasty), hypertension, heart failure, peripheral arterial disease
  • 3.5 Chronic kidney disease (CKD)
  • 3.6 Dementia (only if patients have capacity to provide written informed consent)
  • 3.7 Depression or anxiety
  • 3.8 Diabetes
  • 3.9 Epilepsy
  • 3.10 Fibromyalgia
  • 3.11 Multiple sclerosis
  • 3.12 Osteoporosis or osteopenia
  • 3.13 Parkinson’s disease
  • 3.14 Sensory conditions: including hearing loss, macular degeneration, cataracts, glaucoma
  • 3.15 Stroke within last 5 years
  • 3.16 Bowel problems: including IBS, diverticulitis, inflammatory bowel disease
  • Previous inclusion criteria:
  • 1. Aged 65 years and over (on date of invitation to participate)
  • 2. Community-dwelling (including sheltered living with support),
  • 3. Have two or more chronic conditions from the following list:
  • 3.1 Arthritis: including osteoarthritis, rheumatoid arthritis, and history of shoulder, hip or knee arthroplasty for arthritis
  • 3.2 Asthma or chronic obstructive pulmonary disease (COPD)
  • 3.3 Atrial fibrillation
  • 3.4 A diagnosis of cancer within the last 5 years
  • 3.5 Cardiovascular disease: including coronary heart disease (includes angina or history of heart attack, bypass surgery or angioplasty), hypertension, heart failure, peripheral arterial disease
  • 3.5 Chronic kidney disease
  • 3.6 Dementia (only if capacity to provide written informed consent)
  • 3.7 Depression or anxiety
  • 3.8 Diabetes
  • 3.9 Epilepsy
  • 3.10 Fibromyalgia
  • 3.11 Multiple sclerosis
  • 3.12 Osteoporosis or osteopenia
  • 3.13 Parkinson’s disease
  • 3.14 Sensory conditions: including hearing loss, macular degeneration, glaucoma
  • 3.15 Stroke
  • 3.16 Bowel conditions: including IBS, diverticulitis, inflammatory bowel disease

Exclusion Criteria

  • Current exclusion criteria as of 08/01/2021:
  • 1. Inability to attend one of the yoga courses on offer
  • 2. Attended yoga classes twice a month or more in in the previous 6 months
  • 3. Contraindication to yoga participation (as identified by the patient’s GP)
  • 4. Severe mental health problem (Schizophrenia, bipolar affective disorder or other psychotic illness)
  • 5. Learning disability
  • 6. Unable to read or speak English
  • 7. Unable to provide consent
  • 8. Unable to complete and return a valid baseline questionnaire
  • 9. No more than one patient per household
  • 10. Currently enrolled in another research study for which concurrent participation is deemed inappropriate (by GP or clinical co-investigator)
  • Previous exclusion criteria:
  • 1. Baseline questionnaire not returned
  • 2. Inability to attend one of the yoga courses on offer
  • 3. Performance of yoga in the previous 6 months (defined as twice per month or more)
  • 4. Contraindication to participation (as identified by the patient’s GP)
  • 5. Severe mental health problem (Schizophrenia, bipolar affective disorder or other psychotic illness)
  • 6. Learning disability
  • 7. Unable to read or speak English
  • 8. Unable to provide written informed consent
  • 9. Currently enrolled in another clinical trial where concurrent participation is deemed inappropriate
  • 10. No more than one participant per household may take part

Investigators

Sponsor
orthumbria University Newcastle

Similar Trials